A Study to Develop a Strategy to Increase Lung Cancer Screening in Women Who May Be at Risk for Lung Cancer - Trial NCT04848961
Access comprehensive clinical trial information for NCT04848961 through Pure Global AI's free database. This Early Phase 1 trial is sponsored by Memorial Sloan Kettering Cancer Center and is currently Recruiting. The study focuses on Smoking. Target enrollment is 150 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Memorial Sloan Kettering Cancer Center
Timeline & Enrollment
Early Phase 1
Apr 09, 2021
Apr 09, 2023
Primary Outcome
Number of participants accrued through digital outreach to identify breast screening participants eligible for lung screening
Summary
The purpose of this study is to develop a digital strategy to increase awareness about lung
 cancer screening among women who are eligible to receive it. The digital strategy involves
 email communications and LungTalk, a web-based (accessed through the Internet) health
 communication tool that uses text, audio, video, and animation to increase awareness and
 knowledge about lung cancer screening. This study will focus on women who have recently
 received a screening mammogram.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04848961
Non-Device Trial